Targeted drug delivery to C6 glioma by transferrin-coupled liposomes

Journal of Biomedical Materials Research

Volumn 51, Issue 1, 2000, Pages 10-14

  Eavarone, David A ^a   Yu, Xiaojun ^a   Bellamkonda, Ravi V ^a  

^a Case Western Reserve University   (United States)

Author keywords

Argeted drug delivery; C6 glioma; Doxorubicin; PEG liposome; Transferrin receptor

Indexed keywords

BIOLOGICAL MATERIALS; CHEMOTHERAPY; DRUG PRODUCTS; ENCAPSULATION; ONCOLOGY; POLYETHYLENE GLYCOLS;

DOXORUBICIN; GLIOMA; LIPOSOME; TARGETED DRUG DELIVERY; TRANSFERRIN RECEPTOR;

CONTROLLED DRUG DELIVERY;

DOXORUBICIN; LIPOSOME; MACROGOL; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG UPTAKE; GLIOMA; IN VITRO STUDY; NONHUMAN; RADIOASSAY; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL TRANSPLANTATION; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLIOMA; LIPOSOMES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHARMACEUTIC AIDS; POLYETHYLENE GLYCOLS; RATS; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 0034075131     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R     Document Type: Article

References (24)

1. Kim S. Liposomes as carriers of cancer chemotherapy. Current status and future prospects. Drugs 1993;46:618-638.
2. Woodle MC, Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta 1992;1113:171-199.
3. Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994;15:215-220.
4. Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A, Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1992;1128:44-49.
5. Torchilin VP, Omelyanenko VG, Papisov MI, Bogdanov Jr AA, Trubetskoy VS, Herron JN, Gentry CA. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994;1195:11-20.
6. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991;1066:29-36.
7. Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. [Published erratum appears in Biochim Biophys Acta 1995; 1240(2): 285.] Biochim Biophys Acta 1995;1237:99-108.
8. Blume G, Cevc G, Crommelin MD, Bakker-Woudenberg IA, Kluft C, Storm G. Specific targeting with poly(ethylene glycol)-modified liposomes: Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta 1993;1149:180-184.
9. Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD. Tumor antigens in astrocytic gliomas. Glia 1995;15: 244-256.
10. Recht L, Torres CO, Smith TW, Raso V, Griffin TW. Transferrin receptor in normal and neoplastic brain tissue: Implications for brain-tumor immunotherapy. [See comments.] J Neurosurg 1990;72:941-945.
11. Kung VT, Redemann CT. Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomes. Biochim Biophys Acta 1986;862:435-439.
12. Maruyama K, Takizawa T, Yuda T, Kennel SJ, Huang L, Iwatsuru M. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1995;1234:74-80.
13. Enoch HG, Strittmatter P. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci USA 1979;76:145-149.
14. Mayer LD, Bally MB, Cullis PR. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 1986;857:123-126.
15. Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta 1985;816:294-302.
16. Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995;1233:134-144.
17. Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 1997;54:15-21.
18. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature 1984;312:162-163.
19. Roberts R, Sandra A, Siek GC, Lucas JJ, Fine RE. Studies of the mechanism of iron transport across the blood-brain barrier. Ann Neurol 1992;32:S43-S50.
20. Morris CM, Keith AB, Edwardson JA, Pullen RG. Uptake and distribution of iron and transferrin in the adult rat brain. J Neurochem 1992;59:300-306.
21. Skarlatos S, Yoshikawa T, Pardridge WM. Transport of [1251]transferrin through the rat blood-brain barrier. Brain Res 1995;683:164-171.
22. Descamps L, Dehouck MP, Torpier G, Cecchelli R. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 1996;270:H1149-H1158.
23. van Gelder W, Cleton-Soeteman MI, Huijskes-Heins MI, van Run PR, van Eijk HG. Transcytosis of 6.6-nm gold-labeled transferrin: An ultrastructural study in cultured porcine blood-brain barrier endothelial cells. Brain Res 1997;746:105-116.
24. Broadwell RD, Baker-Cairns BJ, Friden PM, Oliver C, Villegas JC. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Exp Neurol 1996; 142:47-65.